Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GP-Act III Acquisition (GPAT) Non-Current Deffered Revenue (2023 - 2025)

GP-Act III Acquisition (GPAT) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue changed 0.0% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $13.7 million for FY2025, 0.0% changed from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $13.7 million at GP-Act III Acquisition, roughly flat from $13.7 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $13.7 million in Q2 2024, with the low at $526930.0 in Q4 2023.
  • Average Non-Current Deffered Revenue over 3 years is $10.8 million, with a median of $13.7 million recorded in 2024.
  • The sharpest move saw Non-Current Deffered Revenue surged 2497.59% in 2024, then changed 0.0% in 2025.
  • GP-Act III Acquisition's Non-Current Deffered Revenue stood at $526930.0 in 2023, then surged by 2497.59% to $13.7 million in 2024, then changed by 0.0% to $13.7 million in 2025.
  • Per Business Quant, the three most recent readings for GPAT's Non-Current Deffered Revenue are $13.7 million (Q4 2025), $13.7 million (Q3 2025), and $13.7 million (Q2 2025).